The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

DOI record: { "DOI": "10.1007/s00296-021-05056-2", "ISSN": [ "0172-8172", "1437-160X" ], "URL": "http://dx.doi.org/10.1007/s00296-021-05056-2", "alternative-id": [ "5056" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "21 October 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "13 November 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "25 November 2021" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflict of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "Guzin Ozcifci, Tahacan Aydin, Zeynep Atli, Ilker Inanc Balkan, Mert Oztas, Yesim Ozguler, Melike Melikoglu, Izzet Fresko and Vedat Hamuryudan declare that they have no conflict of interest. Fehmi Tabak, has received honoraria, consulting or speaker fees from GSK, MSD, AbbVie and Gilead. Serdal Ugurlu has received honoraria, consulting or speaker fees from Novartis, Pfizer, Lilly and Celltrion. Gulen Hatemi has received research grant from Celgene, honoraria consulting or speaker fees from AbbVie, Amgen, Celgene, Lilly, Novartis and UCB Pharma. Emire Seyahi has received honoraria, consulting or speaker fees from Novartis, Pfizer, AbbVie and Gilead." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "ORCID": "http://orcid.org/0000-0002-4774-9284", "affiliation": [], "authenticated-orcid": false, "family": "Ozcifci", "given": "Guzin", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-8125-4808", "affiliation": [], "authenticated-orcid": false, "family": "Aydin", "given": "Tahacan", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-2959-0978", "affiliation": [], "authenticated-orcid": false, "family": "Atli", "given": "Zeynep", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-8977-5931", "affiliation": [], "authenticated-orcid": false, "family": "Balkan", "given": "Ilker Inanc", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-8632-2825", "affiliation": [], "authenticated-orcid": false, "family": "Tabak", "given": "Fehmi", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-4077-1374", "affiliation": [], "authenticated-orcid": false, "family": "Oztas", "given": "Mert", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-2082-4715", "affiliation": [], "authenticated-orcid": false, "family": "Ozguler", "given": "Yesim", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-9561-2282", "affiliation": [], "authenticated-orcid": false, "family": "Ugurlu", "given": "Serdal", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-1952-1135", "affiliation": [], "authenticated-orcid": false, "family": "Hatemi", "given": "Gulen", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-0253-8368", "affiliation": [], "authenticated-orcid": false, "family": "Melikoglu", "given": "Melike", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-8914-9690", "affiliation": [], "authenticated-orcid": false, "family": "Fresko", "given": "Izzet", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-6625-1652", "affiliation": [], "authenticated-orcid": false, "family": "Hamuryudan", "given": "Vedat", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4965-2918", "affiliation": [], "authenticated-orcid": false, "family": "Seyahi", "given": "Emire", "sequence": "additional" } ], "container-title": "Rheumatology International", "container-title-short": "Rheumatol Int", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2021, 11, 25 ] ], "date-time": "2021-11-25T17:02:46Z", "timestamp": 1637859766000 }, "deposited": { "date-parts": [ [ 2023, 1, 16 ] ], "date-time": "2023-01-16T08:33:32Z", "timestamp": 1673858012000 }, "indexed": { "date-parts": [ [ 2023, 3, 14 ] ], "date-time": "2023-03-14T07:50:44Z", "timestamp": 1678780244501 }, "is-referenced-by-count": 4, "issue": "1", "issued": { "date-parts": [ [ 2021, 11, 25 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2022, 1 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 11, 25 ] ], "date-time": "2021-11-25T00:00:00Z", "timestamp": 1637798400000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 11, 25 ] ], "date-time": "2021-11-25T00:00:00Z", "timestamp": 1637798400000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s00296-021-05056-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s00296-021-05056-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s00296-021-05056-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "101-113", "prefix": "10.1007", "published": { "date-parts": [ [ 2021, 11, 25 ] ] }, "published-online": { "date-parts": [ [ 2021, 11, 25 ] ] }, "published-print": { "date-parts": [ [ 2022, 1 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "5056_CR1", "unstructured": "https://www.worldometers.info/coronavirus/#countries. Accessed 7 September 2021" }, { "key": "5056_CR2", "unstructured": "https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-confirms-first-case-of-coronavirus/1761522. Accessed 11 March 2020" }, { "DOI": "10.1007/s10067-020-05334-7", "author": "C Ferri", "doi-asserted-by": "publisher", "first-page": "3195", "issue": "11", "journal-title": "Clin Rheumatol.", "key": "5056_CR3", "unstructured": "Ferri C, Giuggioli D, Raimondo V, L’Andolina M, Tavoni A, Cecchetti R, Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, Olivo D, Colaci M, Murdaca G, Brittelli R, Mariano GP, Spinella A, Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti R, Brusi V, Meliconi R, Fallahi P, Antonelli A, COVID-19 & ASD Italian Study Group (2020) COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 39(11):3195–3204. https://doi.org/10.1007/s10067-020-05334-7", "volume": "39", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-218296", "author": "JL Pablos", "doi-asserted-by": "publisher", "first-page": "1544", "issue": "12", "journal-title": "Ann Rheum Dis.", "key": "5056_CR4", "unstructured": "Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, Gonzalez-Gay MA, Martinez-Lopez D, Castrejón I, Alvaro-Gracia JM, Fernández Fernández D, Mera-Varela A, Manrique-Arija S, Mena Vázquez N, Fernandez-Nebro A, RIER Investigators Group; RIER investigators group (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 79(12):1544–1549. https://doi.org/10.1136/annrheumdis-2020-218296", "volume": "79", "year": "2020" }, { "DOI": "10.1046/j.1365-4362.2003.01893.x", "author": "G Azizlerli", "doi-asserted-by": "publisher", "first-page": "803", "issue": "10", "journal-title": "Turkey Int J Dermatol", "key": "5056_CR5", "unstructured": "Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R (2003) Prevalence of Behçet’s disease in Istanbul. Turkey Int J Dermatol 42(10):803–806. https://doi.org/10.1046/j.1365-4362.2003.01893.x", "volume": "42", "year": "2003" }, { "DOI": "10.1038/nrrheum.2017.208", "author": "H Yazici", "doi-asserted-by": "publisher", "first-page": "107", "issue": "2", "journal-title": "Nat Rev Rheumatol.", "key": "5056_CR6", "unstructured": "Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol. 14(2):107–119. https://doi.org/10.1038/nrrheum.2017.208 (Epub 2018 Jan 3. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119)", "volume": "14", "year": "2018" }, { "DOI": "10.1056/NEJM199002013220501", "author": "H Yazici", "doi-asserted-by": "publisher", "first-page": "281", "issue": "5", "journal-title": "N Engl J Med", "key": "5056_CR7", "unstructured": "Yazici H, Pazarli H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt GE et al (1990) A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 322(5):281–285. https://doi.org/10.1056/NEJM199002013220501 (PMID: 2404204)", "volume": "322", "year": "1990" }, { "DOI": "10.1093/rheumatology/kei165", "author": "C Mat", "doi-asserted-by": "publisher", "first-page": "348", "issue": "3", "journal-title": "Rheumatology (Oxford)", "key": "5056_CR8", "unstructured": "Mat C, Yurdakul S, Uysal S, Gogus F, Ozyazgan Y, Uysal O, Fresko I, Yazici H (2006) A double-blind trial of depot corticosteroids in Behçet’s syndrome. Rheumatology (Oxford) 45(3):348–352. https://doi.org/10.1093/rheumatology/kei165 (Epub 2005 Nov 1 PMID: 16263779)", "volume": "45", "year": "2006" }, { "DOI": "10.1002/art.21231", "author": "I Tugal-Tutkun", "doi-asserted-by": "publisher", "first-page": "2478", "issue": "8", "journal-title": "Arthritis Rheum", "key": "5056_CR9", "unstructured": "Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trial. Arthritis Rheum 52(8):2478–2484. https://doi.org/10.1002/art.21231 (PMID: 16052571)", "volume": "52", "year": "2005" }, { "DOI": "10.1002/art.40531", "author": "G Emmi", "doi-asserted-by": "publisher", "first-page": "1500", "issue": "9", "journal-title": "Arthritis Rheumatol", "key": "5056_CR10", "unstructured": "Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A, Cantarini L, Prisco D (2018) Adalimumab-based treatment versus disease-modifying antirheumatic drugs for venous thrombosis in Behçet’s Syndrome: a Retrospective Study of Seventy Patients With Vascular Involvement. Arthritis Rheumatol 70(9):1500–1507. https://doi.org/10.1002/art.40531 (Epub 2018 Jul 19 PMID: 29676522)", "volume": "70", "year": "2018" }, { "DOI": "10.1016/j.jaut.2015.06.005", "author": "H Vallet", "doi-asserted-by": "publisher", "first-page": "67", "journal-title": "J Autoimmun", "key": "5056_CR11", "unstructured": "Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behçet Network (2015) Efficacy of anti-TNF alpha in severe and/or refractory Behçet’s disease: Multicenter study of 124 patients. J Autoimmun 62:67–74. https://doi.org/10.1016/j.jaut.2015.06.005", "volume": "62", "year": "2015" }, { "DOI": "10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h", "author": "S Yurdakul", "doi-asserted-by": "publisher", "first-page": "2686", "issue": "11", "journal-title": "Arthritis Rheum", "key": "5056_CR12", "unstructured": "Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H (2001) A double-blind trial of colchicine in Behçet’s syndrome. Arthritis Rheum 44(11):2686–2692. https://doi.org/10.1002/1529-0131(200111)44:11%3c2686::aid-art448%3e3.0.co;2-h (PMID: 11710724)", "volume": "44", "year": "2001" }, { "DOI": "10.1007/s10165-009-0200-2", "author": "F Davatchi", "doi-asserted-by": "publisher", "first-page": "542", "issue": "5", "journal-title": "Mod Rheumatol", "key": "5056_CR13", "unstructured": "Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, Chams-Davatchi C (2009) Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol 19(5):542–549. https://doi.org/10.1007/s10165-009-0200-2 (Epub 2009 Jul 14 PMID: 19597921)", "volume": "19", "year": "2009" }, { "DOI": "10.1007/s11739-020-02427-8", "author": "B Yurttaş", "doi-asserted-by": "publisher", "first-page": "1567", "issue": "8", "journal-title": "Intern Emerg Med", "key": "5056_CR14", "unstructured": "Yurttaş B, Oztas M, Tunc A, Balkan İİ, Tabak OF, Hamuryudan V, Seyahi E (2020) Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients. Intern Emerg Med 15(8):1567–1571. https://doi.org/10.1007/s11739-020-02427-8 (Epub 2020 Jul 9)", "volume": "15", "year": "2020" }, { "DOI": "10.3389/fimmu.2021.651715", "author": "SN Esatoglu", "doi-asserted-by": "publisher", "first-page": "651715", "journal-title": "Front Immunol.", "key": "5056_CR15", "unstructured": "Esatoglu SN, Tascilar K, Babaoğlu H, Bes C, Yurttas B, Akar S, Pehlivan O, Akleylek C, Tecer D, Seyahi E, Yuce-Inel T, Alpay-Kanitez N, Bodakci E, Tekgoz E, Colak S, Bolek EC, Koca SS, Kalyoncu U, Icacan OC, Ugurlu S, Oz HE, Hamuryudan V, Hatemi G, Turkish Society for Rheumatology COVID-19 Registry Investigators (2021) COVID-19 among patients with inflammatory rheumatic diseases. Front Immunol. 12:651715. https://doi.org/10.3389/fimmu.2021.651715", "volume": "12", "year": "2021" }, { "DOI": "10.55563/clinexprheumatol/pmnqmf", "author": "I Mattioli", "doi-asserted-by": "crossref", "first-page": "47", "issue": "5", "journal-title": "Clin Exp Rheumatol.", "key": "5056_CR16", "unstructured": "Mattioli I, Bettiol A, Silvestri E, Urban ML, Palermo A, Fagni F, Malandrino D, Del Bianco A, Prisco D, Emmi G (2021) Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet’s syndrome. Clin Exp Rheumatol. 132(5):47–50 (Epub 2021 Jun 9. PMID: 34128795.)", "volume": "132", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2020-217778", "author": "G Espinosa", "doi-asserted-by": "publisher", "journal-title": "Ann Rheum Dis", "key": "5056_CR17", "unstructured": "Espinosa G, Araujo O, Amaro S, Bodro M, Moreno PJ, Moreno R, Ugarte A, Cervera R (2020) COVID-19 and Behçet’s disease: clinical case series. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217778", "year": "2020" }, { "DOI": "10.1111/jdv.17325", "author": "CC Zouboulis", "doi-asserted-by": "publisher", "first-page": "e541", "issue": "9", "journal-title": "J Eur Acad Dermatol Venereol", "key": "5056_CR18", "unstructured": "Zouboulis CC, van Laar JAM, Schirmer M, Emmi G, Fortune F, Gül A, Kirino Y, Lee ES, Sfikakis PP, Shahram F, Wallace GR (2021) Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19. J Eur Acad Dermatol Venereol 35(9):e541–e543. https://doi.org/10.1111/jdv.17325", "volume": "35", "year": "2021" }, { "key": "5056_CR19", "unstructured": "https://covid19asi.saglik.gov.tr/TR-77707/asi-uygulanacak-grup-siralamasi.html. Accessed 27 March 2021" }, { "key": "5056_CR20", "unstructured": "https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html. Accessed 2020˗2021" }, { "DOI": "10.1016/j.autrev.2020.102575", "author": "G Emmi", "doi-asserted-by": "publisher", "issue": "7", "journal-title": "Autoimmun Rev", "key": "5056_CR21", "unstructured": "Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, Vaglio A, Prisco D (2020) SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev 19(7):102575. https://doi.org/10.1016/j.autrev.2020.102575", "volume": "19", "year": "2020" }, { "author": "WW Daniel", "edition": "7", "key": "5056_CR22", "unstructured": "Daniel WW (1999) Biostatistics: a foundation for analysis in the health sciences, 7th edn. Wiley, New York", "volume-title": "Biostatistics: a foundation for analysis in the health sciences", "year": "1999" }, { "key": "5056_CR23", "unstructured": "https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html. Accessed September 2021" }, { "key": "5056_CR24", "unstructured": "https://data.tuik.gov.tr/Bulten/Index?p=37210. Accessed September 2021" }, { "DOI": "10.1016/S2665-9913(20)30227-7", "author": "J Zhong", "doi-asserted-by": "publisher", "first-page": "e557", "issue": "9", "journal-title": "Lancet Rheumatol", "key": "5056_CR25", "unstructured": "Zhong J, Shen G, Yang H, Huang A, Chen X, Dong L, Wu B, Zhang A, Su L, Hou X, Song S, Li H, Zhou W, Zhou T, Huang Q, Chu A, Braunstein Z, Rao X, Ye C, Dong L (2020) COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol 2(9):e557–e564. https://doi.org/10.1016/S2665-9913(20)30227-7", "volume": "2", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-218946", "author": "S Akiyama", "doi-asserted-by": "publisher", "journal-title": "Ann Rheum Dis", "key": "5056_CR26", "unstructured": "Akiyama S, Hamdeh S, Micic D, Sakuraba A (2020) Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-218946", "year": "2020" }, { "DOI": "10.1016/S2665-9913(21)00151-X", "author": "YH Shin", "doi-asserted-by": "publisher", "first-page": "e698", "issue": "10", "journal-title": "Lancet Rheumatol", "key": "5056_CR27", "unstructured": "Shin YH, Shin JI, Moon SY, Jin HY, Kim SY, Yang JM, Cho SH, Kim S, Lee M, Park Y, Kim MS, Won HH, Hong SH, Kronbichler A, Koyanagi A, Jacob L, Smith L, Lee KH, Suh DI, Lee SW, Yon DK (2021) Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. Lancet Rheumatol 3(10):e698–e706. https://doi.org/10.1016/S2665-9913(21)00151-X", "volume": "3", "year": "2021" }, { "DOI": "10.1007/s00296-020-04626-0", "author": "E Seyahi", "doi-asserted-by": "publisher", "first-page": "1229", "issue": "8", "journal-title": "Rheumatol Int", "key": "5056_CR28", "unstructured": "Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V (2020) The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatol Int 40(8):1229–1238. https://doi.org/10.1007/s00296-020-04626-0", "volume": "40", "year": "2020" }, { "DOI": "10.1177/1076029620938149", "author": "W Miesbach", "doi-asserted-by": "publisher", "journal-title": "Clin Appl Thromb Hemost", "key": "5056_CR29", "unstructured": "Miesbach W, Makris M (2020) COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. https://doi.org/10.1177/1076029620938149 (PMID: 32677459; PMCID: PMC7370334)", "year": "2020" }, { "DOI": "10.1016/S2665-9913(21)00003-5", "author": "P Mehta", "doi-asserted-by": "publisher", "first-page": "e171", "issue": "3", "journal-title": "Lancet Rheumatol.", "key": "5056_CR30", "unstructured": "Mehta P, Haskard DO, Laffan MA, Chambers RC, Hunt BJ (2021) Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis. Lancet Rheumatol. 3(3):e171–e172. https://doi.org/10.1016/S2665-9913(21)00003-5 (Epub 2021 Jan 7. PMID: 33521654; PMCID: PMC7832098)", "volume": "3", "year": "2021" }, { "DOI": "10.1371/journal.pmed.1003379", "author": "CT Rentsch", "doi-asserted-by": "publisher", "issue": "9", "journal-title": "PLoS Med.", "key": "5056_CR31", "unstructured": "Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT Jr, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Lo RV 3rd, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC (2020) Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study. PLoS Med. 17(9):e1003379. https://doi.org/10.1371/journal.pmed.1003379 (PMID: 32960880; PMCID: PMC7508372)", "volume": "17", "year": "2020" }, { "DOI": "10.1371/journal.pone.0243414", "author": "JA Trubiano", "doi-asserted-by": "publisher", "issue": "12", "journal-title": "PLoS ONE", "key": "5056_CR32", "unstructured": "Trubiano JA, Vogrin S, Smibert OC, Marhoon N, Alexander AA, Chua KYL, James FL, Jones NRL, Grigg SE, Xu CLH, Moini N, Stanley SR, Birrell MT, Rose MT, Gordon CL, Kwong JC, Holmes NE (2020) COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2. PLoS ONE 15(12):e0243414. https://doi.org/10.1371/journal.pone.0243414", "volume": "15", "year": "2020" }, { "DOI": "10.1111/add.15276", "author": "D Simons", "doi-asserted-by": "publisher", "first-page": "1319", "issue": "6", "journal-title": "Addiction", "key": "5056_CR33", "unstructured": "Simons D, Shahab L, Brown J, Perski O (2021) The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction 116(6):1319–1368. https://doi.org/10.1111/add.15276", "volume": "116", "year": "2021" }, { "DOI": "10.1093/ntr/ntaa121", "author": "P Tsigaris", "doi-asserted-by": "publisher", "journal-title": "Nicotine Tob Res", "key": "5056_CR34", "unstructured": "Tsigaris P, Teixeira da Silva JA (2020) Smoking Prevalence and COVID-19 in Europe. Nicotine Tob Res. https://doi.org/10.1093/ntr/ntaa121", "year": "2020" }, { "DOI": "10.3390/ijerph17207394", "author": "J González-Rubio", "doi-asserted-by": "publisher", "first-page": "7394", "issue": "20", "journal-title": "Int J Environ Res Public Health", "key": "5056_CR35", "unstructured": "González-Rubio J, Navarro-López C, López-Nájera E, López-Nájera A, Jiménez-Díaz L, Navarro-López JD, Nájera A (2020) A systematic review and meta-analysis of hospitalised current smokers and COVID-19. Int J Environ Res Public Health 17(20):7394. https://doi.org/10.3390/ijerph17207394", "volume": "17", "year": "2020" }, { "DOI": "10.1177/2040622320935765", "author": "K Farsalinos", "doi-asserted-by": "publisher", "first-page": "204062232093576", "issue": "11", "journal-title": "Ther Adv Chronic Dis", "key": "5056_CR36", "unstructured": "Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R (2020) Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Ther Adv Chronic Dis 25(11):2040622320935765. https://doi.org/10.1177/2040622320935765", "volume": "25", "year": "2020" }, { "DOI": "10.1183/13993003.01340-2020", "author": "JM Leung", "doi-asserted-by": "publisher", "first-page": "2001340", "issue": "6", "journal-title": "Eur Respir J", "key": "5056_CR37", "unstructured": "Leung JM, Yang CX, Sin DD (2020) Reply to: “Current smoking is not associated with COVID-19.” Eur Respir J 55(6):2001340. https://doi.org/10.1183/13993003.01340-2020", "volume": "55", "year": "2020" }, { "DOI": "10.1002/jmv.26389", "author": "RK Reddy", "doi-asserted-by": "publisher", "first-page": "1045", "issue": "2", "journal-title": "J Med Virol", "key": "5056_CR38", "unstructured": "Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A (2021) The effect of smoking on COVID-19 severity: a systematic review and meta-analysis. J Med Virol 93(2):1045–1056. https://doi.org/10.1002/jmv.26389", "volume": "93", "year": "2021" }, { "DOI": "10.1093/ntr/ntaa082", "author": "R Patanavanich", "doi-asserted-by": "publisher", "first-page": "1653", "issue": "9", "journal-title": "Nicotine Tob Res", "key": "5056_CR39", "unstructured": "Patanavanich R, Glantz SA (2020) Smoking is associated With COVID-19 progression: a meta-analysis. Nicotine Tob Res 22(9):1653–1656. https://doi.org/10.1093/ntr/ntaa082", "volume": "22", "year": "2020" }, { "DOI": "10.1136/thx.49.8.825", "author": "JA Dye", "doi-asserted-by": "publisher", "first-page": "825", "issue": "8", "journal-title": "Thorax", "key": "5056_CR40", "unstructured": "Dye JA, Adler KB (1994) Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 49(8):825–834. https://doi.org/10.1136/thx.49.8.825", "volume": "49", "year": "1994" }, { "DOI": "10.1183/13993003.01116-2020", "author": "P Russo", "doi-asserted-by": "publisher", "first-page": "2001116", "issue": "6", "journal-title": "Eur Respir J", "key": "5056_CR41", "unstructured": "Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F (2020) COVID-19 and smoking: is nicotine the hidden link? Eur Respir J 55(6):2001116. https://doi.org/10.1183/13993003.01116-2020", "volume": "55", "year": "2020" }, { "DOI": "10.12968/hmed.2008.69.10.31317", "author": "DS Yang", "doi-asserted-by": "publisher", "first-page": "575", "issue": "10", "journal-title": "Br J Hosp Med (Lond)", "key": "5056_CR42", "unstructured": "Yang DS, Taylor SR, Lightman SL (2008) Interferon-alpha in the management of patients with Behçet’s disease. Br J Hosp Med (Lond) 69(10):575–579. https://doi.org/10.12968/hmed.2008.69.10.31317", "volume": "69", "year": "2008" }, { "author": "L Lai", "first-page": "255", "issue": "3", "journal-title": "Int J Nanomedicine.", "key": "5056_CR43", "unstructured": "Lai L, Hui CK, Leung N, Lau GK (2006) Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B. Int J Nanomedicine. 1(3):255–62 (PMID: 17717966; PMCID: PMC2426802)", "volume": "1", "year": "2006" }, { "DOI": "10.1016/j.bpg.2012.09.013", "author": "JJ Feld", "doi-asserted-by": "publisher", "first-page": "429", "issue": "4", "journal-title": "Best Pract Res Clin Gastroenterol", "key": "5056_CR44", "unstructured": "Feld JJ (2012) Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection. Best Pract Res Clin Gastroenterol 26(4):429–444. https://doi.org/10.1016/j.bpg.2012.09.013", "volume": "26", "year": "2012" }, { "DOI": "10.3389/fimmu.2020.615275.Erratumfor:FrontImmunol.2020May15;11:1061", "author": "Q Zhou", "doi-asserted-by": "publisher", "issue": "11", "journal-title": "Front Immunol", "key": "5056_CR45", "unstructured": "Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN (2020) Corrigendum: interferon-α2b treatment for COVID-19. Front Immunol 27(11):615275. https://doi.org/10.3389/fimmu.2020.615275.Erratumfor:FrontImmunol.2020May15;11:1061", "volume": "27", "year": "2020" }, { "DOI": "10.1001/jama.290.24.3222", "author": "MR Loutfy", "doi-asserted-by": "publisher", "first-page": "3222", "issue": "24", "journal-title": "JAMA", "key": "5056_CR46", "unstructured": "Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, Deif H, LaMere EA, Chang M, Kain KC, Farcas GA, Ferguson P, Latchford M, Levy G, Dennis JW, Lai EK, Fish EN (2003) Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290(24):3222–3228. https://doi.org/10.1001/jama.290.24.3222", "volume": "290", "year": "2003" }, { "DOI": "10.1126/science.abd4570", "author": "Q Zhang", "doi-asserted-by": "publisher", "journal-title": "Science.", "key": "5056_CR47", "unstructured": "Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. https://doi.org/10.1126/science.abd4570", "year": "2020" }, { "DOI": "10.1126/science.abc6027", "author": "J Hadjadj", "doi-asserted-by": "publisher", "first-page": "718", "issue": "6504", "journal-title": "Science", "key": "5056_CR48", "unstructured": "Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504):718–724. https://doi.org/10.1126/science.abc6027", "volume": "369", "year": "2020" }, { "DOI": "10.2174/1381612824666180123110042", "author": "C Angelidis", "doi-asserted-by": "publisher", "first-page": "659", "issue": "6", "journal-title": "Curr Pharm Des", "key": "5056_CR49", "unstructured": "Angelidis C, Kotsialou Z, Kossyvakis C, Vrettou AR, Zacharoulis A, Kolokathis F, Kekeris V, Giannopoulos G (2018) Colchicine Pharmacokinetics and Mechanism of Action. Curr Pharm Des 24(6):659–663. https://doi.org/10.2174/1381612824666180123110042", "volume": "24", "year": "2018" }, { "DOI": "10.1016/j.ejim.2010.09.010", "author": "G Cocco", "doi-asserted-by": "publisher", "first-page": "503", "issue": "6", "journal-title": "Eur J Intern Med.", "key": "5056_CR50", "unstructured": "Cocco G, Chu DC, Pandolfi S (2010) Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 21(6):503–8. https://doi.org/10.1016/j.ejim.2010.09.010", "volume": "21", "year": "2010" }, { "DOI": "10.1002/cmdc.201800641", "author": "M Richter", "doi-asserted-by": "publisher", "first-page": "469", "issue": "4", "journal-title": "ChemMedChem", "key": "5056_CR51", "unstructured": "Richter M, Boldescu V, Graf D, Streicher F, Dimoglo A, Bartenschlager R, Klein CD (2019) Synthesis, biological evaluation, and molecular docking of combretastatin and colchicine derivatives and their hCE1-Activated Prodrugs as Antiviral Agents. ChemMedChem 14(4):469–483. https://doi.org/10.1002/cmdc.201800641", "volume": "14", "year": "2019" }, { "DOI": "10.1001/jamanetworkopen.2020.13136", "author": "SG Deftereos", "doi-asserted-by": "publisher", "first-page": "2013136", "issue": "6", "journal-title": "JAMA Netw Open.", "key": "5056_CR52", "unstructured": "Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C, GRECCO-19 investigators (2020) Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 3(6):2013136. https://doi.org/10.1001/jamanetworkopen.2020.13136", "volume": "3", "year": "2020" }, { "DOI": "10.1371/journal.pone.0248276", "author": "L Manenti", "doi-asserted-by": "publisher", "issue": "3", "journal-title": "PLoS ONE", "key": "5056_CR53", "unstructured": "Manenti L, Maggiore U, Fiaccadori E, Meschi T, Antoni AD, Nouvenne A, Ticinesi A, Cerundolo N, Prati B, Delsante M, Gandoflini I, Donghi L, Gentile M, Farina MT, Oliva V, Zambrano C, Regolisti G, Palmisano A, Caminiti C, Cocchi E, Ferrari C, Riella LV, Cravedi P, Peruzzi L (2021) Reduced mortality in COVID-19 patients treated with colchicine: results from a retrospective, observational study. PLoS ONE 16(3):e0248276. https://doi.org/10.1371/journal.pone.0248276", "volume": "16", "year": "2021" }, { "DOI": "10.1136/rmdopen-2020-001455", "author": "MI Lopes", "doi-asserted-by": "publisher", "issue": "1", "journal-title": "RMD Open", "key": "5056_CR54", "unstructured": "Lopes MI, Bonjorno LP, Giannini MC, Amaral NB, Menezes PI, Dib SM, Gigante SL, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida SCL, Luppino Assad R, Veras FP, Schneider A, Rodrigues TS, Leiria LOS, Cunha LD, Alves-Filho JC, Cunha TM, Arruda E, Miranda CH, Pazin-Filho A, Auxiliadora-Martins M, Borges MC, Fonseca BAL, Bollela VR, Del-Ben CM, Cunha FQ, Zamboni DS, Santana RC, Vilar FC, Louzada-Junior P, Oliveira RDR (2021) Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 7(1):e001455. https://doi.org/10.1136/rmdopen-2020-001455", "volume": "7", "year": "2021" }, { "DOI": "10.1016/S2213-2600(21)00222-8", "author": "JC Tardif", "doi-asserted-by": "publisher", "first-page": "924", "issue": "8", "journal-title": "Lancet Respir Med.", "key": "5056_CR55", "unstructured": "Tardif JC, Bouabdallaoui N, L’Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault A, Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, Lesage F, Sainturet N, Roy-Clavel E, Bassevitch Z, Orfanos A, Stamatescu G, Grégoire JC, Busque L, Lavallée C, Hétu PO, Paquette JS, Deftereos SG, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dubé MP, Guertin MC, Boivin G, COLCORONA Investigators (2021) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 9(8):924–932. https://doi.org/10.1016/S2213-2600(21)00222-8", "volume": "9", "year": "2021" }, { "DOI": "10.1016/j.autrev.2020.102566", "author": "O Gendelman", "doi-asserted-by": "publisher", "issue": "7", "journal-title": "Autoimmun Rev", "key": "5056_CR56", "unstructured": "Gendelman O, Amital H, Bragazzi NL, Watad A, Chodick G (2020) Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. Autoimmun Rev 19(7):102566. https://doi.org/10.1016/j.autrev.2020.102566", "volume": "19", "year": "2020" }, { "DOI": "10.1177/1759720X211002684", "author": "A Madrid-García", "doi-asserted-by": "publisher", "journal-title": "Ther Adv Musculoskelet Dis.", "key": "5056_CR57", "unstructured": "Madrid-García A, Pérez I, Colomer JI, León-Mateos L, Jover JA, Fernández-Gutiérrez B, Abásolo-Alcazar L, Rodríguez-Rodríguez L (2021) Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis. Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720X211002684", "year": "2021" }, { "DOI": "10.1007/s00296-021-04809-3", "author": "K Nas", "doi-asserted-by": "publisher", "first-page": "811", "issue": "4", "journal-title": "Rheumatol Int", "key": "5056_CR58", "unstructured": "Nas K, Eryilmaz N, Geyik MF, Altaş A (2021) COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review. Rheumatol Int 41(4):811–817. https://doi.org/10.1007/s00296-021-04809-3", "volume": "41", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2020-218707", "author": "R Bourguiba", "doi-asserted-by": "publisher", "journal-title": "Ann Rheum Dis", "key": "5056_CR59", "unstructured": "Bourguiba R, Delplanque M, Vinit C, Ackermann F, Savey L, Grateau G, Hentgen V, Georgin-Lavialle S (2020) Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-218707", "year": "2020" }, { "DOI": "10.1038/s41584-020-00562-2.PMID:33339986;PMCID:PMC7747184", "author": "KL Hyrich", "doi-asserted-by": "publisher", "first-page": "71", "issue": "2", "journal-title": "Nat Rev Rheumatol", "key": "5056_CR60", "unstructured": "Hyrich KL, Machado PM (2021) Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 17(2):71–72. https://doi.org/10.1038/s41584-020-00562-2.PMID:33339986;PMCID:PMC7747184", "volume": "17", "year": "2021" }, { "DOI": "10.1007/s00038-020-01390-7", "author": "V Jain", "doi-asserted-by": "publisher", "first-page": "533", "issue": "5", "journal-title": "Int J Public Health", "key": "5056_CR61", "unstructured": "Jain V, Yuan JM (2020) Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 65(5):533–546. https://doi.org/10.1007/s00038-020-01390-7", "volume": "65", "year": "2020" } ], "reference-count": 61, "references-count": 61, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s00296-021-05056-2" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Immunology", "Immunology and Allergy", "Rheumatology" ], "subtitle": [], "title": "The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "42" }